The Lidar Radar Open Software Environment (LROSE): An End-to-End Suite of Applications for Radar and Lidar Processing
Journal of Open Research Software · 16.04.2026 · 14
DOI: 10.5334/jors.630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Open Research Software, erschienen am 16.04.2026. Verfasst von Michael Dixon und 5 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Gefördert von: National Center for Atmospheric Research, US National Science Foundation.
Abstract (Originalsprache)
The Lidar Radar Open Software Environment (LROSE) is a suite of high-performance C++ applications for format conversion, quality control, visualization, and analysis of weather radar and lidar data, developed over 30 years at the U.S. National Science Foundation National Center for Atmospheric Research (NSF NCAR) and Colorado State University (CSU). Distributed under a Berkeley Software Distribution (BSD) license on GitHub, LROSE supports real-time and archival scientific analysis workflows. Future distribution via the conda-forge Python channel is planned.
Förderung
- National Center for Atmospheric Research
- US National Science Foundation
Zitieren
APA
Dixon, M., DeHart, J., Javornik, B., Cha, T., Bell, M., & Lee, W. (2026). The Lidar Radar Open Software Environment (LROSE): An End-to-End Suite of Applications for Radar and Lidar Processing. Journal of Open Research Software, 14. https://doi.org/10.5334/jors.630
Vancouver
Dixon M, DeHart J, Javornik B, Cha T, Bell M, Lee W. The Lidar Radar Open Software Environment (LROSE): An End-to-End Suite of Applications for Radar and Lidar Processing. Journal of Open Research Software. 2026;14. doi:10.5334/jors.630
BibTeX
@article{Dixon2026,
author = {Dixon, Michael and DeHart, Jennifer and Javornik, Brenda and Cha, Ting-Yu and Bell, Michael and Lee, Wen-Chau},
title = {The Lidar Radar Open Software Environment (LROSE): An End-to-End Suite of Applications for Radar and Lidar Processing},
journal = {Journal of Open Research Software},
year = {2026},
volume = {14},
doi = {10.5334/jors.630}
}
EUVIMED